What is the emergency management for a patient with ruptured esophageal varices?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Emergency Management of Ruptured Esophageal Varices

When esophageal varices rupture and are actively bleeding, you must immediately initiate vasoactive drug therapy (terlipressin, octreotide, or somatostatin), start antibiotic prophylaxis with ceftriaxone, perform restrictive blood transfusion targeting hemoglobin 7-9 g/dL, and arrange urgent endoscopy within 12 hours for endoscopic band ligation. 1

Immediate Resuscitation (First 30 Minutes)

Airway, Breathing, Circulation

  • Secure airway and establish large-bore IV access (at least two catheters) to allow rapid volume expansion 2
  • Restore blood volume with crystalloids - no benefit shown with colloids over crystalloids 2
  • Restrictive transfusion strategy: Transfuse red blood cells only when hemoglobin drops below 7 g/dL, with target range of 7-9 g/dL post-transfusion 1, 3
    • This restrictive approach improves outcomes compared to liberal transfusion
    • Higher thresholds may be needed only in massive hemorrhage or patients unable to mount physiological response to anemia 2

Immediate Pharmacotherapy (Before Endoscopy)

Start vasoactive drugs immediately upon suspicion of variceal bleeding - do not wait for endoscopic confirmation 1

Choose ONE of the following 1:

  • Terlipressin: 2 mg IV every 4 hours for first 48 hours, then 1 mg every 4-6 hours 2, 1
  • Octreotide: 50 µg IV bolus, then 50 µg/hour continuous infusion 2, 1
  • Somatostatin: 250 µg IV bolus, then 250 µg/hour continuous infusion (can increase to 500 µg/hour) 2, 1

All three agents have equivalent efficacy for hemostasis and survival 1. Continue vasoactive therapy for 3-5 days to prevent early rebleeding 2, 1.

Antibiotic Prophylaxis (Critical)

Start ceftriaxone 1 g IV daily immediately - continue for up to 7 days 1, 3

  • Antibiotic prophylaxis reduces mortality and infection risk in all patients with acute variceal bleeding 1
  • Alternative: norfloxacin if ceftriaxone unavailable 2
  • Adjust based on local antibiotic resistance patterns 1

Pre-Endoscopy Preparation

Administer erythromycin 250 mg IV 30-120 minutes before endoscopy (if no contraindications) 3

  • Improves visualization by promoting gastric emptying

Endoscopic Management (Within 12 Hours)

Timing and Approach

  • Perform endoscopy within 12 hours after hemodynamic resuscitation is achieved 2, 1, 3
  • Earlier endoscopy (≤12 hours) associated with lower 6-week rebleeding rate (18.9% vs 38.9%) and mortality (27% vs 52.8%) 1

Endoscopic Treatment

Endoscopic band ligation (EVL) is the treatment of choice for acute esophageal variceal hemorrhage 1, 3

  • EVL superior to sclerotherapy with lower rebleeding risk (RR 0.68) and higher eradication rates 1
  • Sclerotherapy no longer recommended as standard treatment due to higher failure rates and complications 1

Rescue Therapy for Treatment Failure

Definition of Treatment Failure

Failure occurs when bleeding continues despite combined pharmacological and endoscopic therapy, defined as 1:

  • Fresh hematemesis ≥2 hours after treatment start
  • Development of hypovolemic shock
  • Hemoglobin drop of 3 g/dL within 24 hours without transfusion

Rescue Options (in order of preference)

1. Transjugular Intrahepatic Portosystemic Shunt (TIPS)

  • TIPS is the best rescue treatment for inadequate bleeding control 1, 3
  • Achieves hemostasis in 90% of patients who fail endoscopic therapy 1
  • Should be performed urgently when available 3

2. Balloon Tamponade (Bridge Therapy Only)

  • Provides temporary hemostasis in 80-90% but rebleeding rate is 50% after deflation 1
  • Critical limitation: Must not exceed 24 hours due to high risk of serious complications (esophageal ulceration, rupture, aspiration pneumonia) 1
  • Use only as bridge to definitive therapy (TIPS or transplant) 1

3. Self-Expandable Esophageal Metal Stent

  • Alternative to balloon tamponade with better bleeding control (85% vs 47%) and fewer serious adverse events (15% vs 47%) 1
  • Can remain in place up to 2 weeks 1
  • Placed endoscopically without radiological guidance 1

High-Risk Patient Management

For patients at high risk of rebleeding, consider pre-emptive early TIPS within 72 hours (preferably within 24 hours) 3

High-risk criteria include 3:

  • Child-Pugh C score ≤13, OR
  • Child-Pugh B with active bleeding at endoscopy despite vasoactive agents, OR
  • Hepatic venous pressure gradient >20 mmHg

Common Pitfalls to Avoid

  • Do NOT over-transfuse: Liberal transfusion worsens portal pressure and increases rebleeding risk 2, 1
  • Do NOT delay vasoactive drugs: Start immediately on suspicion, before endoscopy 1
  • Do NOT forget antibiotics: Antibiotic prophylaxis is mandatory and reduces mortality 1
  • Do NOT leave balloon tamponade >24 hours: High complication risk including esophageal rupture 1
  • Do NOT use sclerotherapy as first-line: EVL is superior 1

Post-Hemostasis Management

After successful initial control 1:

  • Continue vasoactive drugs for 3-5 days
  • Continue antibiotics for up to 7 days
  • Schedule repeat EVL every 1-4 weeks until variceal eradication 3
  • Initiate non-selective beta blockers (propranolol or carvedilol) for secondary prophylaxis 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.